Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
---|---|---|---|---|---|---|---|---|
NPO33513 | hydrangeae dulcis folium | Species | NA | NA |
PMID[9871657] |
|||
NPO9360.1 | Hydrangea macrophylla var. thunbergii | Varieties | Hydrangeaceae | Eukaryota | Leaves |
PMID[17609121] |
||
NPO11100 | Artemisia capillaris | Species | Asteraceae | Eukaryota | HerDing* | |||
NPO19581 | Marchantia polymorpha | Species | Marchantiaceae | Eukaryota | HerDing* | |||
NPO11100 | Artemisia capillaris | Species | Asteraceae | Eukaryota | TCMID* | |||
NPO19581 | Marchantia polymorpha | Species | Marchantiaceae | Eukaryota | TCMID* |
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT520 | Cell Line | 3T3-L1 | Mus musculus | Activity | = | 8 | % | 17609121 |
NPT520 | Cell Line | 3T3-L1 | Mus musculus | Activity | = | 19.6 | % | 17609121 |
NPT520 | Cell Line | 3T3-L1 | Mus musculus | Activity | = | 15.7 | % | 17609121 |
NPT520 | Cell Line | 3T3-L1 | Mus musculus | Activity | = | -27.6 | % | 17609121 |
NPT520 | Cell Line | 3T3-L1 | Mus musculus | Activity | = | 17.5 | % | 17609121 |
NPT532 | Individual Protein | Lysine-specific demethylase 4A | Homo sapiens | Potency | 89125.1 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 32642.7 | nM | PubChem BioAssay data set | ||
NPT64 | Individual Protein | ATPase family AAA domain-containing protein 5 | Homo sapiens | Potency | 16353.5 | nM | PubChem BioAssay data set | |
NPT64 | Individual Protein | ATPase family AAA domain-containing protein 5 | Homo sapiens | Potency | 7304.8 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 19952.6 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 9200 | nM | PubChem BioAssay data set | ||
NPT8 | Individual Protein | DNA polymerase iota | Homo sapiens | Potency | 70794.6 | nM | PubChem BioAssay data set | |
NPT803 | Individual Protein | Flap endonuclease 1 | Homo sapiens | Potency | 44668.4 | nM | PubChem BioAssay data set | |
NPT9 | Individual Protein | DNA polymerase eta | Homo sapiens | Potency | 35481.3 | nM | PubChem BioAssay data set | |
NPT199 | Individual Protein | DNA polymerase kappa | Homo sapiens | Potency | 79432.8 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 2818.4 | nM | PubChem BioAssay data set | ||
NPT368 | Cell Line | SN12C | Homo sapiens | GI50 | 14354.89 | nM | PubChem BioAssay data set | |
NPT370 | Cell Line | NCI-H23 | Homo sapiens | GI50 | 16069.41 | nM | PubChem BioAssay data set | |
NPT371 | Cell Line | UO-31 | Homo sapiens | GI50 | 14723.13 | nM | PubChem BioAssay data set | |
NPT369 | Cell Line | ACHN | Homo sapiens | GI50 | 21428.91 | nM | PubChem BioAssay data set | |
NPT116 | Cell Line | HL-60 | Homo sapiens | GI50 | 17060.82 | nM | PubChem BioAssay data set | |
NPT372 | Cell Line | HOP-92 | Homo sapiens | GI50 | 2065.38 | nM | PubChem BioAssay data set | |
NPT90 | Cell Line | DU-145 | Homo sapiens | GI50 | 23768.4 | nM | PubChem BioAssay data set | |
NPT374 | Cell Line | SF-539 | Homo sapiens | GI50 | 23933.16 | nM | PubChem BioAssay data set | |
NPT373 | Cell Line | SK-MEL-5 | Homo sapiens | GI50 | 9397.23 | nM | PubChem BioAssay data set | |
NPT375 | Cell Line | Malme-3M | Homo sapiens | GI50 | 31260.79 | nM | PubChem BioAssay data set | |
NPT376 | Cell Line | A498 | Homo sapiens | GI50 | 19906.73 | nM | PubChem BioAssay data set | |
NPT111 | Cell Line | K562 | Homo sapiens | GI50 | 22130.95 | nM | PubChem BioAssay data set | |
NPT377 | Cell Line | OVCAR-3 | Homo sapiens | GI50 | 10519.62 | nM | PubChem BioAssay data set | |
NPT112 | Cell Line | MOLT-4 | Homo sapiens | GI50 | 3419.79 | nM | PubChem BioAssay data set | |
NPT379 | Cell Line | HOP-62 | Homo sapiens | GI50 | 15240.53 | nM | PubChem BioAssay data set | |
NPT378 | Cell Line | NCI/ADR-RES | Homo sapiens | GI50 | 14621.77 | nM | PubChem BioAssay data set | |
NPT382 | Cell Line | OVCAR-5 | Homo sapiens | GI50 | 22029.26 | nM | PubChem BioAssay data set | |
NPT381 | Cell Line | OVCAR-8 | Homo sapiens | GI50 | 36643.76 | nM | PubChem BioAssay data set | |
NPT383 | Cell Line | SNB-19 | Homo sapiens | GI50 | 19098.53 | nM | PubChem BioAssay data set | |
NPT323 | Cell Line | SW-620 | Homo sapiens | GI50 | 21086.28 | nM | PubChem BioAssay data set | |
NPT384 | Cell Line | TK-10 | Homo sapiens | GI50 | 4897.79 | nM | PubChem BioAssay data set | |
NPT455 | Cell Line | NCI-H522 | Homo sapiens | GI50 | 15417 | nM | PubChem BioAssay data set | |
NPT386 | Cell Line | KM12 | Homo sapiens | GI50 | 11376.27 | nM | PubChem BioAssay data set | |
NPT387 | Cell Line | M14 | Homo sapiens | GI50 | 19453.6 | nM | PubChem BioAssay data set | |
NPT389 | Cell Line | RPMI-8226 | Homo sapiens | GI50 | 10471.29 | nM | PubChem BioAssay data set | |
NPT388 | Cell Line | NCI-H322M | Homo sapiens | GI50 | 3572.73 | nM | PubChem BioAssay data set | |
NPT456 | Cell Line | OVCAR-4 | Homo sapiens | GI50 | 20090.93 | nM | PubChem BioAssay data set | |
NPT457 | Cell Line | BT-549 | Homo sapiens | GI50 | 15559.66 | nM | PubChem BioAssay data set | |
NPT147 | Cell Line | SK-MEL-2 | Homo sapiens | GI50 | 26121.61 | nM | PubChem BioAssay data set | |
NPT81 | Cell Line | A549 | Homo sapiens | GI50 | 35399.73 | nM | PubChem BioAssay data set | |
NPT391 | Cell Line | HCC 2998 | Homo sapiens | GI50 | 12764.39 | nM | PubChem BioAssay data set | |
NPT392 | Cell Line | SNB-75 | Homo sapiens | GI50 | 23120.65 | nM | PubChem BioAssay data set | |
NPT148 | Cell Line | HCT-15 | Homo sapiens | GI50 | 4988.84 | nM | PubChem BioAssay data set | |
NPT395 | Cell Line | SF-268 | Homo sapiens | GI50 | 19769.7 | nM | PubChem BioAssay data set | |
NPT393 | Cell Line | HCT-116 | Homo sapiens | GI50 | 10327.61 | nM | PubChem BioAssay data set | |
NPT394 | Cell Line | EKVX | Homo sapiens | GI50 | 14060.48 | nM | PubChem BioAssay data set | |
NPT83 | Cell Line | MCF7 | Homo sapiens | GI50 | 9571.94 | nM | PubChem BioAssay data set | |
NPT306 | Cell Line | PC-3 | Homo sapiens | GI50 | 11091.75 | nM | PubChem BioAssay data set | |
NPT146 | Cell Line | SK-OV-3 | Homo sapiens | GI50 | 29376.5 | nM | PubChem BioAssay data set | |
NPT396 | Cell Line | T47D | Homo sapiens | GI50 | 870.96 | nM | PubChem BioAssay data set | |
NPT397 | Cell Line | NCI-H460 | Homo sapiens | GI50 | 13427.65 | nM | PubChem BioAssay data set | |
NPT400 | Cell Line | MDA-MB-435 | Homo sapiens | GI50 | 24210.29 | nM | PubChem BioAssay data set | |
NPT308 | Cell Line | CAKI-1 | Homo sapiens | GI50 | 6714.29 | nM | PubChem BioAssay data set | |
NPT458 | Cell Line | IGROV-1 | Homo sapiens | GI50 | 6194.41 | nM | PubChem BioAssay data set | |
NPT399 | Cell Line | SF-295 | Homo sapiens | GI50 | 27478.94 | nM | PubChem BioAssay data set | |
NPT402 | Cell Line | Hs-578T | Homo sapiens | GI50 | 21232.44 | nM | PubChem BioAssay data set | |
NPT403 | Cell Line | UACC-257 | Homo sapiens | GI50 | 22594.36 | nM | PubChem BioAssay data set | |
NPT401 | Cell Line | 786-0 | Homo sapiens | GI50 | 19633.6 | nM | PubChem BioAssay data set | |
NPT404 | Cell Line | CCRF-CEM | Homo sapiens | GI50 | 997.7 | nM | PubChem BioAssay data set | |
NPT406 | Cell Line | RXF 393 | Homo sapiens | GI50 | 18879.91 | nM | PubChem BioAssay data set | |
NPT407 | Cell Line | COLO 205 | Homo sapiens | GI50 | 10543.87 | nM | PubChem BioAssay data set | |
NPT10 | Individual Protein | Geminin | Homo sapiens | Potency | 7307.8 | nM | PubChem BioAssay data set | |
NPT1474 | Individual Protein | ATP-dependent Clp protease proteolytic subunit | Bacillus subtilis (strain 168) | Potency | 31622.8 | nM | PubChem BioAssay data set | |
NPT1852 | Individual Protein | Rac GTPase-activating protein 1 | Homo sapiens | IC50 | 19650 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | IC50 | 20720 | nM | PubChem BioAssay data set | ||
NPT100 | Individual Protein | Glutaminase kidney isoform, mitochondrial | Homo sapiens | Potency | 35481.3 | nM | PubChem BioAssay data set | |
NPT156 | Individual Protein | Sphingomyelin phosphodiesterase | Homo sapiens | Potency | 25118.9 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 31622.8 | nM | PubChem BioAssay data set | ||
NPT10 | Individual Protein | Geminin | Homo sapiens | Potency | 16360.1 | nM | PubChem BioAssay data set | |
NPT101 | Individual Protein | Glucagon-like peptide 1 receptor | Homo sapiens | Potency | 3981.1 | nM | PubChem BioAssay data set | |
NPT821 | Individual Protein | Werner syndrome ATP-dependent helicase | Homo sapiens | Potency | 35481.3 | nM | PubChem BioAssay data set | |
NPT755 | Individual Protein | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Homo sapiens | Potency | 79432.8 | nM | PubChem BioAssay data set | |
NPT152 | Individual Protein | Nuclear factor erythroid 2-related factor 2 | Homo sapiens | Potency | 31622.8 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 18356.4 | nM | PubChem BioAssay data set |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC134969 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
0.9635 | High Similarity | NPC257025 |
0.9407 | High Similarity | NPC62907 |
0.9155 | High Similarity | NPC476463 |
0.8973 | High Similarity | NPC295646 |
0.8936 | High Similarity | NPC314271 |
0.8929 | High Similarity | NPC290664 |
0.8873 | High Similarity | NPC258307 |
0.8873 | High Similarity | NPC470130 |
0.8865 | High Similarity | NPC91546 |
0.8857 | High Similarity | NPC471819 |
0.8849 | High Similarity | NPC261292 |
0.8849 | High Similarity | NPC301915 |
0.8819 | High Similarity | NPC32058 |
0.8819 | High Similarity | NPC138978 |
0.8819 | High Similarity | NPC85734 |
0.8811 | High Similarity | NPC279121 |
0.8792 | High Similarity | NPC227062 |
0.8777 | High Similarity | NPC156307 |
0.8776 | High Similarity | NPC204350 |
0.8768 | High Similarity | NPC175943 |
0.875 | High Similarity | NPC70136 |
0.8741 | High Similarity | NPC175013 |
0.8732 | High Similarity | NPC130485 |
0.8723 | High Similarity | NPC191280 |
0.8723 | High Similarity | NPC247409 |
0.8722 | High Similarity | NPC91475 |
0.8722 | High Similarity | NPC265910 |
0.869 | High Similarity | NPC179271 |
0.869 | High Similarity | NPC20791 |
0.8676 | High Similarity | NPC94810 |
0.8662 | High Similarity | NPC155205 |
0.8643 | High Similarity | NPC223836 |
0.8636 | High Similarity | NPC198336 |
0.863 | High Similarity | NPC130230 |
0.863 | High Similarity | NPC108406 |
0.863 | High Similarity | NPC74881 |
0.863 | High Similarity | NPC239312 |
0.863 | High Similarity | NPC51443 |
0.863 | High Similarity | NPC275772 |
0.86 | High Similarity | NPC56786 |
0.86 | High Similarity | NPC20541 |
0.86 | High Similarity | NPC80534 |
0.8581 | High Similarity | NPC85131 |
0.8571 | High Similarity | NPC283514 |
0.8571 | High Similarity | NPC12367 |
0.8571 | High Similarity | NPC72918 |
0.8571 | High Similarity | NPC119059 |
0.8571 | High Similarity | NPC118726 |
0.8571 | High Similarity | NPC477689 |
0.8562 | High Similarity | NPC169749 |
0.8552 | High Similarity | NPC38065 |
0.8552 | High Similarity | NPC242893 |
0.8543 | High Similarity | NPC54928 |
0.8543 | High Similarity | NPC153512 |
0.8529 | High Similarity | NPC181715 |
0.8523 | High Similarity | NPC202157 |
0.8521 | High Similarity | NPC197666 |
0.8521 | High Similarity | NPC126739 |
0.8514 | High Similarity | NPC183950 |
0.8514 | High Similarity | NPC216318 |
0.8514 | High Similarity | NPC270465 |
0.8514 | High Similarity | NPC287101 |
0.8514 | High Similarity | NPC17286 |
0.8514 | High Similarity | NPC52005 |
0.8514 | High Similarity | NPC259713 |
0.8514 | High Similarity | NPC195351 |
0.8514 | High Similarity | NPC87125 |
0.8514 | High Similarity | NPC296197 |
0.8514 | High Similarity | NPC137062 |
0.8514 | High Similarity | NPC223579 |
0.8511 | High Similarity | NPC326847 |
0.8511 | High Similarity | NPC50455 |
0.8506 | High Similarity | NPC22324 |
0.8503 | High Similarity | NPC155910 |
0.8503 | High Similarity | NPC17042 |
0.8503 | High Similarity | NPC168803 |
0.85 | High Similarity | NPC106406 |
0.8493 | Intermediate Similarity | NPC262282 |
0.8487 | Intermediate Similarity | NPC273843 |
0.8477 | Intermediate Similarity | NPC67396 |
0.8477 | Intermediate Similarity | NPC38898 |
0.8472 | Intermediate Similarity | NPC220106 |
0.8472 | Intermediate Similarity | NPC158634 |
0.8467 | Intermediate Similarity | NPC199773 |
0.8462 | Intermediate Similarity | NPC268052 |
0.8462 | Intermediate Similarity | NPC32360 |
0.8456 | Intermediate Similarity | NPC3825 |
0.8456 | Intermediate Similarity | NPC286342 |
0.8456 | Intermediate Similarity | NPC96501 |
0.8456 | Intermediate Similarity | NPC295036 |
0.8456 | Intermediate Similarity | NPC184136 |
0.8456 | Intermediate Similarity | NPC151473 |
0.8456 | Intermediate Similarity | NPC188871 |
0.8456 | Intermediate Similarity | NPC88804 |
0.8456 | Intermediate Similarity | NPC45873 |
0.8456 | Intermediate Similarity | NPC149127 |
0.8456 | Intermediate Similarity | NPC77858 |
0.8446 | Intermediate Similarity | NPC321011 |
0.8446 | Intermediate Similarity | NPC294852 |
0.8446 | Intermediate Similarity | NPC276930 |
0.8446 | Intermediate Similarity | NPC218490 |
0.8446 | Intermediate Similarity | NPC120464 |
0.8446 | Intermediate Similarity | NPC188679 |
0.8431 | Intermediate Similarity | NPC474290 |
0.8431 | Intermediate Similarity | NPC238381 |
0.8431 | Intermediate Similarity | NPC280680 |
0.8429 | Intermediate Similarity | NPC289572 |
0.8429 | Intermediate Similarity | NPC157478 |
0.8429 | Intermediate Similarity | NPC153783 |
0.8429 | Intermediate Similarity | NPC295406 |
0.8429 | Intermediate Similarity | NPC200422 |
0.8421 | Intermediate Similarity | NPC24640 |
0.8421 | Intermediate Similarity | NPC475799 |
0.8421 | Intermediate Similarity | NPC13779 |
0.8417 | Intermediate Similarity | NPC189823 |
0.8417 | Intermediate Similarity | NPC214702 |
0.8417 | Intermediate Similarity | NPC219892 |
0.8417 | Intermediate Similarity | NPC470831 |
0.8414 | Intermediate Similarity | NPC301178 |
0.8414 | Intermediate Similarity | NPC82913 |
0.8414 | Intermediate Similarity | NPC250755 |
0.8414 | Intermediate Similarity | NPC284556 |
0.8414 | Intermediate Similarity | NPC322112 |
0.8414 | Intermediate Similarity | NPC105648 |
0.8411 | Intermediate Similarity | NPC185103 |
0.8411 | Intermediate Similarity | NPC281703 |
0.8411 | Intermediate Similarity | NPC125487 |
0.8411 | Intermediate Similarity | NPC281477 |
0.8411 | Intermediate Similarity | NPC89474 |
0.8403 | Intermediate Similarity | NPC158472 |
0.84 | Intermediate Similarity | NPC225731 |
0.84 | Intermediate Similarity | NPC125062 |
0.84 | Intermediate Similarity | NPC260895 |
0.84 | Intermediate Similarity | NPC252933 |
0.84 | Intermediate Similarity | NPC200740 |
0.84 | Intermediate Similarity | NPC54394 |
0.8392 | Intermediate Similarity | NPC257173 |
0.8392 | Intermediate Similarity | NPC233780 |
0.8389 | Intermediate Similarity | NPC1612 |
0.8389 | Intermediate Similarity | NPC48479 |
0.8389 | Intermediate Similarity | NPC177298 |
0.8389 | Intermediate Similarity | NPC183959 |
0.838 | Intermediate Similarity | NPC235115 |
0.838 | Intermediate Similarity | NPC324929 |
0.838 | Intermediate Similarity | NPC160425 |
0.838 | Intermediate Similarity | NPC291454 |
0.8378 | Intermediate Similarity | NPC125449 |
0.8378 | Intermediate Similarity | NPC188074 |
0.8378 | Intermediate Similarity | NPC95864 |
0.8378 | Intermediate Similarity | NPC12200 |
0.8377 | Intermediate Similarity | NPC130955 |
0.8377 | Intermediate Similarity | NPC139036 |
0.8377 | Intermediate Similarity | NPC200594 |
0.8367 | Intermediate Similarity | NPC32470 |
0.8366 | Intermediate Similarity | NPC143328 |
0.8356 | Intermediate Similarity | NPC183824 |
0.8356 | Intermediate Similarity | NPC287722 |
0.8356 | Intermediate Similarity | NPC471417 |
0.8355 | Intermediate Similarity | NPC82592 |
0.8355 | Intermediate Similarity | NPC16286 |
0.8355 | Intermediate Similarity | NPC16082 |
0.8355 | Intermediate Similarity | NPC199926 |
0.8355 | Intermediate Similarity | NPC471800 |
0.8345 | Intermediate Similarity | NPC233056 |
0.8345 | Intermediate Similarity | NPC26697 |
0.8345 | Intermediate Similarity | NPC244441 |
0.8344 | Intermediate Similarity | NPC301323 |
0.8344 | Intermediate Similarity | NPC156222 |
0.8344 | Intermediate Similarity | NPC39732 |
0.8344 | Intermediate Similarity | NPC162313 |
0.8344 | Intermediate Similarity | NPC120163 |
0.8344 | Intermediate Similarity | NPC131624 |
0.8344 | Intermediate Similarity | NPC222830 |
0.8344 | Intermediate Similarity | NPC198826 |
0.8344 | Intermediate Similarity | NPC275836 |
0.8344 | Intermediate Similarity | NPC289968 |
0.8344 | Intermediate Similarity | NPC63187 |
0.8344 | Intermediate Similarity | NPC212678 |
0.8344 | Intermediate Similarity | NPC279989 |
0.8344 | Intermediate Similarity | NPC293183 |
0.8344 | Intermediate Similarity | NPC241498 |
0.8344 | Intermediate Similarity | NPC256283 |
0.8344 | Intermediate Similarity | NPC25270 |
0.8344 | Intermediate Similarity | NPC27208 |
0.8344 | Intermediate Similarity | NPC184284 |
0.8344 | Intermediate Similarity | NPC82325 |
0.8344 | Intermediate Similarity | NPC275722 |
0.8344 | Intermediate Similarity | NPC239128 |
0.8344 | Intermediate Similarity | NPC157784 |
0.8344 | Intermediate Similarity | NPC71334 |
0.8344 | Intermediate Similarity | NPC187498 |
0.8344 | Intermediate Similarity | NPC57030 |
0.8344 | Intermediate Similarity | NPC60972 |
0.8344 | Intermediate Similarity | NPC167903 |
0.8344 | Intermediate Similarity | NPC100887 |
0.8344 | Intermediate Similarity | NPC37684 |
0.8344 | Intermediate Similarity | NPC76041 |
0.8344 | Intermediate Similarity | NPC188203 |
0.8344 | Intermediate Similarity | NPC55205 |
0.8344 | Intermediate Similarity | NPC115249 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC134969 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.8811 | High Similarity | NPD1511 | Approved |
0.869 | High Similarity | NPD1512 | Approved |
0.8462 | Intermediate Similarity | NPD970 | Clinical (unspecified phase) |
0.8289 | Intermediate Similarity | NPD2801 | Approved |
0.8227 | Intermediate Similarity | NPD943 | Approved |
0.8224 | Intermediate Similarity | NPD1934 | Approved |
0.8219 | Intermediate Similarity | NPD3750 | Approved |
0.817 | Intermediate Similarity | NPD2393 | Clinical (unspecified phase) |
0.817 | Intermediate Similarity | NPD1465 | Phase 2 |
0.8169 | Intermediate Similarity | NPD230 | Phase 1 |
0.8153 | Intermediate Similarity | NPD6232 | Discontinued |
0.8125 | Intermediate Similarity | NPD651 | Clinical (unspecified phase) |
0.8117 | Intermediate Similarity | NPD3817 | Phase 2 |
0.8085 | Intermediate Similarity | NPD3764 | Approved |
0.8069 | Intermediate Similarity | NPD2935 | Discontinued |
0.8042 | Intermediate Similarity | NPD447 | Suspended |
0.8 | Intermediate Similarity | NPD7473 | Discontinued |
0.8 | Intermediate Similarity | NPD1510 | Phase 2 |
0.7986 | Intermediate Similarity | NPD1203 | Approved |
0.7956 | Intermediate Similarity | NPD1201 | Approved |
0.7949 | Intermediate Similarity | NPD4868 | Clinical (unspecified phase) |
0.7945 | Intermediate Similarity | NPD5405 | Approved |
0.7945 | Intermediate Similarity | NPD5404 | Approved |
0.7945 | Intermediate Similarity | NPD5406 | Approved |
0.7945 | Intermediate Similarity | NPD5408 | Approved |
0.7877 | Intermediate Similarity | NPD3748 | Approved |
0.7857 | Intermediate Similarity | NPD1470 | Approved |
0.784 | Intermediate Similarity | NPD3818 | Discontinued |
0.7834 | Intermediate Similarity | NPD3882 | Suspended |
0.7823 | Intermediate Similarity | NPD1551 | Phase 2 |
0.7821 | Intermediate Similarity | NPD7819 | Suspended |
0.7818 | Intermediate Similarity | NPD4338 | Clinical (unspecified phase) |
0.7792 | Intermediate Similarity | NPD3226 | Approved |
0.7791 | Intermediate Similarity | NPD7054 | Approved |
0.7778 | Intermediate Similarity | NPD9493 | Approved |
0.777 | Intermediate Similarity | NPD1552 | Clinical (unspecified phase) |
0.777 | Intermediate Similarity | NPD1550 | Clinical (unspecified phase) |
0.777 | Intermediate Similarity | NPD9269 | Phase 2 |
0.777 | Intermediate Similarity | NPD2346 | Discontinued |
0.7763 | Intermediate Similarity | NPD4378 | Clinical (unspecified phase) |
0.7744 | Intermediate Similarity | NPD7472 | Approved |
0.7742 | Intermediate Similarity | NPD4380 | Phase 2 |
0.773 | Intermediate Similarity | NPD1164 | Approved |
0.7724 | Intermediate Similarity | NPD1240 | Approved |
0.7718 | Intermediate Similarity | NPD1549 | Phase 2 |
0.7716 | Intermediate Similarity | NPD6168 | Clinical (unspecified phase) |
0.7716 | Intermediate Similarity | NPD6166 | Phase 2 |
0.7716 | Intermediate Similarity | NPD6167 | Clinical (unspecified phase) |
0.7708 | Intermediate Similarity | NPD2313 | Discontinued |
0.7697 | Intermediate Similarity | NPD6797 | Phase 2 |
0.7692 | Intermediate Similarity | NPD1529 | Clinical (unspecified phase) |
0.7682 | Intermediate Similarity | NPD6190 | Approved |
0.7673 | Intermediate Similarity | NPD3749 | Approved |
0.7658 | Intermediate Similarity | NPD5402 | Approved |
0.7651 | Intermediate Similarity | NPD7251 | Discontinued |
0.7647 | Intermediate Similarity | NPD2534 | Approved |
0.7647 | Intermediate Similarity | NPD2533 | Approved |
0.7647 | Intermediate Similarity | NPD7422 | Clinical (unspecified phase) |
0.7647 | Intermediate Similarity | NPD2532 | Approved |
0.7643 | Intermediate Similarity | NPD9717 | Approved |
0.7636 | Intermediate Similarity | NPD7074 | Phase 3 |
0.7635 | Intermediate Similarity | NPD1509 | Clinical (unspecified phase) |
0.7622 | Intermediate Similarity | NPD1530 | Clinical (unspecified phase) |
0.7619 | Intermediate Similarity | NPD1607 | Approved |
0.7582 | Intermediate Similarity | NPD6799 | Approved |
0.7576 | Intermediate Similarity | NPD5844 | Phase 1 |
0.7562 | Intermediate Similarity | NPD4381 | Clinical (unspecified phase) |
0.7562 | Intermediate Similarity | NPD7075 | Discontinued |
0.7551 | Intermediate Similarity | NPD1933 | Approved |
0.7548 | Intermediate Similarity | NPD5403 | Approved |
0.7544 | Intermediate Similarity | NPD8397 | Clinical (unspecified phase) |
0.7536 | Intermediate Similarity | NPD9545 | Approved |
0.7532 | Intermediate Similarity | NPD5401 | Approved |
0.7518 | Intermediate Similarity | NPD405 | Clinical (unspecified phase) |
0.7517 | Intermediate Similarity | NPD2799 | Discontinued |
0.7516 | Intermediate Similarity | NPD6234 | Discontinued |
0.75 | Intermediate Similarity | NPD1878 | Clinical (unspecified phase) |
0.75 | Intermediate Similarity | NPD7808 | Phase 3 |
0.75 | Intermediate Similarity | NPD7768 | Phase 2 |
0.7484 | Intermediate Similarity | NPD7096 | Clinical (unspecified phase) |
0.7483 | Intermediate Similarity | NPD1613 | Approved |
0.7483 | Intermediate Similarity | NPD2797 | Approved |
0.7483 | Intermediate Similarity | NPD1612 | Clinical (unspecified phase) |
0.7482 | Intermediate Similarity | NPD9268 | Approved |
0.7468 | Intermediate Similarity | NPD6143 | Clinical (unspecified phase) |
0.7466 | Intermediate Similarity | NPD411 | Approved |
0.7444 | Intermediate Similarity | NPD74 | Approved |
0.7444 | Intermediate Similarity | NPD9266 | Approved |
0.7432 | Intermediate Similarity | NPD1899 | Clinical (unspecified phase) |
0.7431 | Intermediate Similarity | NPD2798 | Approved |
0.7421 | Intermediate Similarity | NPD6801 | Discontinued |
0.7419 | Intermediate Similarity | NPD7410 | Clinical (unspecified phase) |
0.7417 | Intermediate Similarity | NPD7266 | Discontinued |
0.7413 | Intermediate Similarity | NPD3225 | Approved |
0.7405 | Intermediate Similarity | NPD6599 | Discontinued |
0.74 | Intermediate Similarity | NPD4308 | Phase 3 |
0.7394 | Intermediate Similarity | NPD1608 | Approved |
0.7386 | Intermediate Similarity | NPD8166 | Discontinued |
0.7386 | Intermediate Similarity | NPD4628 | Phase 3 |
0.7381 | Intermediate Similarity | NPD7993 | Clinical (unspecified phase) |
0.7368 | Intermediate Similarity | NPD9264 | Approved |
0.7368 | Intermediate Similarity | NPD9267 | Approved |
0.7368 | Intermediate Similarity | NPD9263 | Approved |
0.7358 | Intermediate Similarity | NPD7411 | Suspended |
0.7355 | Intermediate Similarity | NPD7390 | Discontinued |
0.7351 | Intermediate Similarity | NPD2796 | Approved |
0.7347 | Intermediate Similarity | NPD3268 | Approved |
0.7329 | Intermediate Similarity | NPD4288 | Approved |
0.7329 | Intermediate Similarity | NPD6832 | Phase 2 |
0.7324 | Intermediate Similarity | NPD422 | Phase 1 |
0.732 | Intermediate Similarity | NPD7421 | Clinical (unspecified phase) |
0.7317 | Intermediate Similarity | NPD6959 | Discontinued |
0.7312 | Intermediate Similarity | NPD37 | Approved |
0.7301 | Intermediate Similarity | NPD919 | Approved |
0.7292 | Intermediate Similarity | NPD1283 | Approved |
0.7284 | Intermediate Similarity | NPD4965 | Approved |
0.7284 | Intermediate Similarity | NPD4967 | Phase 2 |
0.7284 | Intermediate Similarity | NPD4966 | Approved |
0.7278 | Intermediate Similarity | NPD1653 | Approved |
0.7273 | Intermediate Similarity | NPD1481 | Phase 2 |
0.726 | Intermediate Similarity | NPD9494 | Approved |
0.7256 | Intermediate Similarity | NPD5494 | Approved |
0.7251 | Intermediate Similarity | NPD8312 | Approved |
0.7251 | Intermediate Similarity | NPD8313 | Approved |
0.7235 | Intermediate Similarity | NPD7685 | Pre-registration |
0.7235 | Intermediate Similarity | NPD6559 | Discontinued |
0.7233 | Intermediate Similarity | NPD5808 | Clinical (unspecified phase) |
0.7233 | Intermediate Similarity | NPD3455 | Phase 2 |
0.723 | Intermediate Similarity | NPD6859 | Clinical (unspecified phase) |
0.7225 | Intermediate Similarity | NPD8150 | Discontinued |
0.7222 | Intermediate Similarity | NPD8443 | Clinical (unspecified phase) |
0.7222 | Intermediate Similarity | NPD4379 | Clinical (unspecified phase) |
0.7215 | Intermediate Similarity | NPD6980 | Clinical (unspecified phase) |
0.7212 | Intermediate Similarity | NPD7199 | Phase 2 |
0.7208 | Intermediate Similarity | NPD1243 | Approved |
0.7203 | Intermediate Similarity | NPD1535 | Discovery |
0.7202 | Intermediate Similarity | NPD7228 | Approved |
0.719 | Intermediate Similarity | NPD2344 | Approved |
0.7186 | Intermediate Similarity | NPD7852 | Clinical (unspecified phase) |
0.7183 | Intermediate Similarity | NPD17 | Approved |
0.7179 | Intermediate Similarity | NPD3300 | Phase 2 |
0.7162 | Intermediate Similarity | NPD3027 | Phase 3 |
0.7161 | Intermediate Similarity | NPD6398 | Clinical (unspecified phase) |
0.7161 | Intermediate Similarity | NPD7003 | Approved |
0.716 | Intermediate Similarity | NPD7804 | Clinical (unspecified phase) |
0.7159 | Intermediate Similarity | NPD7879 | Clinical (unspecified phase) |
0.7133 | Intermediate Similarity | NPD4060 | Phase 1 |
0.7133 | Intermediate Similarity | NPD4307 | Phase 2 |
0.7126 | Intermediate Similarity | NPD7184 | Clinical (unspecified phase) |
0.7123 | Intermediate Similarity | NPD3266 | Approved |
0.7123 | Intermediate Similarity | NPD3267 | Approved |
0.7122 | Intermediate Similarity | NPD9281 | Approved |
0.7111 | Intermediate Similarity | NPD9265 | Clinical (unspecified phase) |
0.7107 | Intermediate Similarity | NPD920 | Approved |
0.7101 | Intermediate Similarity | NPD3751 | Discontinued |
0.7097 | Intermediate Similarity | NPD2800 | Approved |
0.7089 | Intermediate Similarity | NPD7004 | Clinical (unspecified phase) |
0.7089 | Intermediate Similarity | NPD642 | Clinical (unspecified phase) |
0.7083 | Intermediate Similarity | NPD1547 | Clinical (unspecified phase) |
0.7083 | Intermediate Similarity | NPD1281 | Approved |
0.7078 | Intermediate Similarity | NPD2029 | Clinical (unspecified phase) |
0.7075 | Intermediate Similarity | NPD1019 | Discontinued |
0.707 | Intermediate Similarity | NPD643 | Clinical (unspecified phase) |
0.7069 | Intermediate Similarity | NPD8055 | Clinical (unspecified phase) |
0.7068 | Intermediate Similarity | NPD9261 | Approved |
0.7066 | Intermediate Similarity | NPD5710 | Approved |
0.7066 | Intermediate Similarity | NPD5711 | Approved |
0.7059 | Intermediate Similarity | NPD7033 | Discontinued |
0.7042 | Intermediate Similarity | NPD1548 | Phase 1 |
0.7013 | Intermediate Similarity | NPD9570 | Approved |
0.7007 | Intermediate Similarity | NPD3022 | Approved |
0.7007 | Intermediate Similarity | NPD3021 | Approved |
0.7006 | Intermediate Similarity | NPD1247 | Approved |
0.7006 | Intermediate Similarity | NPD2309 | Approved |
0.7 | Intermediate Similarity | NPD1296 | Phase 2 |
0.7 | Intermediate Similarity | NPD6798 | Discontinued |
0.6974 | Remote Similarity | NPD6355 | Discontinued |
0.6966 | Remote Similarity | NPD1610 | Phase 2 |
0.6964 | Remote Similarity | NPD3787 | Discontinued |
0.6954 | Remote Similarity | NPD6233 | Phase 2 |
0.6954 | Remote Similarity | NPD520 | Approved |
0.6944 | Remote Similarity | NPD4626 | Approved |
0.6937 | Remote Similarity | NPD6273 | Approved |
0.6933 | Remote Similarity | NPD7095 | Approved |
0.6933 | Remote Similarity | NPD6386 | Approved |
0.6933 | Remote Similarity | NPD6385 | Approved |
0.6923 | Remote Similarity | NPD3926 | Phase 2 |
0.6908 | Remote Similarity | NPD2979 | Phase 3 |
0.6906 | Remote Similarity | NPD228 | Approved |
0.6903 | Remote Similarity | NPD6100 | Approved |
0.6903 | Remote Similarity | NPD6099 | Approved |
0.6848 | Remote Similarity | NPD8455 | Phase 2 |
0.6846 | Remote Similarity | NPD258 | Approved |
0.6846 | Remote Similarity | NPD257 | Approved |
0.6824 | Remote Similarity | NPD5242 | Approved |
0.6824 | Remote Similarity | NPD1876 | Approved |
0.6821 | Remote Similarity | NPD4625 | Phase 3 |
0.681 | Remote Similarity | NPD7458 | Discontinued |
0.6806 | Remote Similarity | NPD1894 | Discontinued |
0.6805 | Remote Similarity | NPD8127 | Discontinued |
PubChem CID   | 5321948 |
ChEMBL   | CHEMBL68810 |
ZINC   |
Molecular Weight:   | 270.05 |
ALogP:   | -1.451 |
MLogP:   | 2.56 |
XLogP:   | 3.091 |
# Rotatable Bonds:   | 4 |
Polar Surface Area:   | 86.99 |
# H-Bond Aceptor:   | 2 |
# H-Bond Donor:   | 3 |
# Rings:   | 3 |
# Heavy Atoms:   | 20 |